An Internet health service platform, NGES, is upgrading its product architecture to 2.0 with AI.
In recent years, health information has continued to receive public attention, and the service capability of the industry has continued to improve. On April 28, at the 2026 Tencent Cloud City Summit in Chongqing, an Internet health service platform officially released the upgrade to the NGES product architecture 2. 0, and launched the NGESMedAgentSuite, based on a new architecture, that hits the deepest pain points in medical information delivery, compliance regulation and business transformation for pharmaceutical companies.
Wang Yi, product and technology director of an Internet health services platform, said that AI is evolving rapidly from Chatbot to Agents and even Innovators. This initiative marks a strategic upgrading of an Internet health services platform in the field of digital marketing for pharmaceutical companies, pushing the digital system of pharmaceutical companies from traditional logging tools to a new era of growth engines. In the field of medical health, AI has penetrated the entire medical process, showing a transformative power in value chains such as the commercialization of pharmaceutical companies, clinical practice support, internal improvement.
From Chatbot that understands language, to Reasoner with the ability to solve problems at doctoral level, to AgenticAI that can plan, make decisions, and act independently, the technological revolution is reshaping the underlying logic of the healthcare industry. In this context, the industry is generally faced with three core pain points: one, the low efficiency of medical information transmission, the difficulty of matching traditional representative visits with changes in the digital behaviour of doctors; second, the high cost of compliance and quality control, the lack of real-time intelligent auditing of bulk medical content and behaviour; third, the dormant data value, the number of existing systems stuck at the bottom of the database, and the failure to convert medical interactive data into the core assets that drive growth. On the physician side, 41% of physicians are accustomed to using AI tools regularly, 59% are more likely to access medical information through WeChat graphics messages, making efficient, uninterrupted digital access the first choice; on the pharmaceutical side, AI is also penetrating every link from drug discovery, manufacturing to commercialization.
The underlying architecture is based on medical knowledge graphs and data centers, the middle layer is centered on a modular Agent capability engine, and the upper layer provides flexible application interfaces for pharmaceutical marketing, medicine, compliance and other scenarios. NGES 2. 0 product architecture upgrades: Overview of the evolution of the NGES product architecture with the introduction of the NGES 2.
0 product architecture. Unlike traditional consolidation software, NGES 2. 0 breaks down the capabilities of medical content understanding, compliance auditing, data analysis, etc.
into standardized, reusable Agent modules. It can be predicted that as technology progresses and demands are upgraded, this area will also open up new development space. NGESClaw's three Agency capabilities: From human-driven AI to computational-assisted AI.
Currently, pharmaceutical marketing faces real-world challenges such as high production thresholds for medical content, backlog of compliance audits, lack of data insights. Pharmaceuticals can combine freely based on their business needs, such as assembling Lego blocks, rapidly organizing, building proprietary intelligence to achieve intelligent collaboration that goes from simple task automation to complex cross-sectoral workflows. With NGES enhancement assistants embedded in daily communication, real-time speech recommendations, retrieval of matching information, and professional support available without the need to switch systems.
Based on the NGES 2. 0 architecture, an Internet health service platform officially released the NGESMedAgentSuite and introduced three core capabilities: intelligent medical assistants: a deep fusion of pharmaceutical industry knowledge charts and large models, providing medical content support for pharmaceutical representatives 7×24 hours. Conformity content quality checks: focusing on the core demands of pharmaceutical compliance regulation, building a unified AI intelligence management center, conducting comprehensive, multi-dimensional compliance checks on multiple scenarios such as micro-conferences, marketing content, online conferences.
It is widely believed that standardization and specialization will be key words for future development. At the same time, relying on MedAgentSuite's long-term memory capabilities, continuous learning of user preferences, and personalized recommendations from general response to ensure the accuracy and professionalism of medical information delivery. Specifically, in the online meeting scenario, the introduction of real-time risk prevention capability screening sessions for compliance monitoring and immediate suggestions on how to translate post-compliance review into prior prevention and intervention.
AI-based dual engine (NLP+ General NLP+ Medicines Exclusive Engine), accurate identification of hyper-adaptation manifestations, unapproved publicity language, discourse bias, and other risk items, coverage of text, voice, images, videos, and other types of messages. Automatically generate physician 360-degree dynamic images, output accurate actions based on image and market strategy recommendations for who to visit, what topics to talk about, and what to recommend today; Managers can use natural language to directly query business data, dialogue is insight. Smart decision-making brains: as a decision center, to integrate InsightAgent in MedAgentSuite, NBA/NBCAgent with ChatBIAgent, to access internal and external multi-source data.
Not only is it a 'recorder' of data, but it is also a 'thinker' of business, from insight into strategy to verification of outcomes to complete enclosures that help with data-driven precision decision-making. Remember: based on long-term accumulated medical knowledge charts, clinical practice guidebooks and interactive data, it builds deep medical memory systems. Doctors are accustomed to getting medical information in WeChat, providing natural, efficient and low-disturbance channels for pharmaceutical companies to touch.
NGES+AI can continue to learn and immerse itself in the context of each interaction, forming an enterprise-level medical asset of a sustainable generation. The mission of the pharmaceutical enterprise digital system is undergoing a fundamental transformation. At the same time, all AI capabilities strictly adhere to clinical practice norms, through certification such as the Department of Public Security's Level Three, complete chain encryption and de-identification processing, ensuring service reliability and control.
In the future, an Internet health services platform will continue to deepen the integration of NGES+AI with the WeChat ecosystem and the Tencent Cloud infrastructure, work with industry partners to move healthcare from service-focused to service-focused, to make quality medical resources and medical innovation reach more corners, and to create new healthcare ecosystems. Through three Agency collaborations, the production, review, transmission, and feedback of medical content will be fully automated. Through the intelligent brain, management gained forward-looking insights to achieve the transition from a cloud-driven experience to a cloud-driven data-driven cloud.
Statement: The web forwarded this article to provide readers with more information, the content involved does not constitute investment and consumer advice. The facts of the article if in doubt, please verify with relevant parties, the article views are not from the web, readers only reference. The International Health Service System of China is constantly monitoring the latest developments in the field of healthcare, providing you with authority, reliable information and medical services.
If you have further consultation needs on related content, welcome to contact authoritative experts via the platform.
